Clinical trial
Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia
NCT00100971 · Boston Medical Center, Other · Terminated
Key facts
| NCT number | NCT00100971 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia |
| Official title | Dendritic/Leukemic Fusion Cell Vaccine Therapy For AML Patients In First Remission; A Phase I Clinical Trial |
| Lead sponsor | Boston Medical Center, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug, Procedure |
| Interventions | autologous tumor cell vaccine, therapeutic autologous dendritic cells, tumor cell-derivative vaccine therapy |
| Enrollment | 9 |
| Start date | Apr 1, 2004 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Jan 10, 2005 |
| Last update posted | Jan 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: